CERE - Cerevel Therapeutics Holdings Inc. (CERE) CEO Tony Coles on Q2 2021 Results - Earnings Call Transcript
Cerevel Therapeutics Holdings, Inc. (CERE) Q2 2021 Earnings Conference Call August 11, 2021 08:00 ET Company Participants Matthew Calistri - Vice President of Investor Relations Tony Coles - Chairperson & Chief Executive Officer Ray Sanchez - Chief Medical Officer John Renger - Chief Scientific Officer Kathy Yi - Chief Financial Officer Conference Call Participants Paul Matteis - Stifel Michael Yee - Jefferies Kostas Biliouris - Morgan Stanley Greg Suvannavejh - Goldman Sachs Presentation Operator Good morning. Welcome to the Cerevel Therapeutics Second Quarter 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, you will have the opportunity to ask questions during the Q&A portion of the call. Please note that this call maybe recorded. I will now hand the call over to Mr. Matthew Calistri, Vice President of Corporate Strategy and Investor Relations. Matthew Calistri Thank you. Good morning, everyone. We appreciate you
For further details see:
Cerevel Therapeutics Holdings, Inc. (CERE) CEO Tony Coles on Q2 2021 Results - Earnings Call Transcript